PURAC BIOQUIMICA, S.A.

Montmelo, SpainFEI 3003789425API manufacture registered

PURAC BIOQUIMICA, S.A. is a drug establishment in Montmelo, Spain, registered with the US FDA under FEI 3003789425. Its registered operations are: API manufacture. 2 EU/UK GMP certificates are matched to this site, 1 inspected within the last three years. FDA has published 5 inspection outcomes for this FEI; the most recent, ended 7 Sept 2022, was classified voluntary action indicated (VAI).

Sources: FDA Drug Establishments Current Registration Site (checked 16 Nov 2026); FDA Data Dashboard (inspections); EudraGMDP; MHRA GMDP. Methodology

Cite as: PharmaTek, “PURAC BIOQUIMICA, S.A.: FDA registration, inspection and GMP record (FEI 3003789425)”, record as of 16 Nov 2026, pharmatek.co.uk/manufacturing-sites/purac-bioquimica-s-a-montmelo-3003789425

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

API manufacture

GMP documents matched to this site (2)

DocumentAuthorityInspectionSource
NCF-II/2624/001/CAT
GMP certificate
Competent authority of Spain5 Mar 2026
within 3-year review window
EudraGMDP
NCF-II/2521/001/CAT
GMP certificate
Competent authority of Spain5 Sept 2022
outside 3-year review window
EudraGMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

FDA inspection outcomes (5)

Inspection endedOutcomeProgramme areaCitations posted
7 Sept 2022VAI · Voluntary action indicatedDrug Quality AssuranceNo
20 Apr 2018VAI · Voluntary action indicatedDrug Quality AssuranceNo
20 Jan 2018VAI · Voluntary action indicatedDrug Quality AssuranceNo
21 Apr 2016OAI · Official action indicatedDrug Quality AssuranceNo
30 May 2013VAI · Voluntary action indicatedDrug Quality AssuranceNo

FDA Data Dashboard, joined on the FEI. NAI: no objectionable conditions found. VAI: objectionable conditions found, but not serious enough for regulatory action. OAI: regulatory or administrative action recommended. A classification describes one inspection on one date; FDA publishes it only once final and does not publish every inspection. FDA firm profile

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • The full text of a Form 483 or warning letter: FDA's dashboard gives the regulation cited and a short description only.
For suppliers

Is this PURAC BIOQUIMICA SAU?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.